Approaches to Mental Illness
Readers respond to an Opinion guest essay by Daniel Bergner that questioned mandatory psychiatric treatment.
The Business of Being Chris Christie
Mr. Christie left the governor’s office in New Jersey and set out to, as he put it, “make money.” He successfully traded on his political profile — and on his ties to the man he now wants to defeat.
Cancer Drug Advancements Give New Hope to Metastatic Patients
New treatments are changing once deadly forms of the disease into manageable long-term illnesses. But not all patients are benefiting.
New Obesity Drugs Come With a Side Effect of Shaming
Wegovy and other drugs expose a social tension between a quest to medicate illness and a stigmatizing belief that obese people lack sufficient willpower to lose weight.
FDA Panel Recommends RSV Shot to Protect Infants
Advisers to the agency overwhelmingly agreed that a new treatment would help to prevent a potentially lethal respiratory illness in very young children.
When Politics Saves Lives: a Good-News Story
The decision to fund medications to treat H.I.V.-AIDS patients in sub-Saharan Africa and the Caribbean flew in the face of expert advice. But the U.S. did it anyway.
Merck Sues Over Medicare Drug-Price Negotiation Law
The company is heavily reliant on a cancer drug that could be targeted by a program intended to lower drug prices.
A Major Problem With Compulsory Mental Health Care Is the Medication
An underdiscussed issue with forced mental health care.
How to Fix the National Drug Shortage
The way health care providers negotiate drug prices has put the squeeze on manufacturers.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.